Rat and cell experiments linked the gene-regulating protein ETS1 to kidney injury after interrupted blood flow was restored. Reducing ETS1 lowered PARP1, a protein participating in DNA damage responses, alongside several injury measures. The peer-reviewed study also used cells derived from human kidney tubules, while clinical protection in patients remains untested.
Suppressing ETS1, a protein that regulates gene activity, reduced several measures of kidney injury in peer-reviewed rat experiments. The injury followed interruption and restoration of renal blood flow. Tissue images, blood urea nitrogen and creatinine were used to assess damage, alongside measures of DNA damage. The illustrated animal comparisons involved six animals per group, while many cell comparisons used three replicates.[1]
The experiments traced a link with PARP1, a protein involved in the DNA damage response. Lowering ETS1 reduced PARP1; restoring a higher PARP1 level partly counteracted the cellular protection. After identifying the potential connection in databases, researchers examined binding and gene activity experimentally. Cell work used HK2 cells derived from human kidney tubules, subjected to oxygen–glucose deprivation and then reoxygenation. Patient outcomes were not tested.[1]
Veliparib and PJ34, substances that inhibit PARP1, reduced injury indicators in rats. Cell experiments recorded higher viability-related measurements, together with lower markers for cell death and DNA damage. Some inflammatory markers fell after ETS1 reduction as well. The authors acknowledge the absence of quantitative tissue-injury scoring and incomplete characterization of downstream PARP1 pathways. They also discuss previous work finding protective ETS1 associations in other organs and conditions.[1]
